Second line of treatment for HER2-positive gastric cancer: an evolving issue

著者: Roviello, Giandomenico, Catalano, Martina, D’Angelo, Alberto, Palmieri, Valeria Emma
出版年 Rep Pract Oncol Radiother (2021)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights

著者: Roviello, Giandomenico, D'Angelo, Alberto, Roudi, Raheleh, Petrioli, Roberto, Mini, Enrico
出版年 J Oncol (2019)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

著者: Roviello, Giandomenico, Corona, Silvia Paola, D’Angelo, Alberto, Rosellini, Pietro, Nobili, Stefania, Mini, Enrico
出版年 Int J Mol Sci (2020)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy

著者: Rodriquenz, Maria Grazia, Roviello, Giandomenico, D’Angelo, Alberto, Lavacchi, Daniele, Roviello, Franco, Polom, Karol
出版年 J Clin Med (2020)

Mutant p53 as an Antigen in Cancer Immunotherapy

著者: Sobhani, Navid, D’Angelo, Alberto, Wang, Xu, Young, Ken H., Generali, Daniele, Li, Yong
出版年 Int J Mol Sci (2020)

Advances in anti-BRAF therapies for lung cancer

著者: Roviello, Giandomenico, D’Angelo, Alberto, Sirico, Marianna, Pittacolo, Matteo, Conter, Felipe Umpierre, Sobhani, Navid
出版年 Invest New Drugs (2021)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

著者: Roviello, Giandomenico, D'Angelo, Alberto, Petrioli, Roberto, Roviello, Franco, Cianchi, Fabio, Nobili, Stefania, Mini, Enrico, Lavacchi, Daniele
出版年 Transl Oncol (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

著者: Sobhani, Navid, Ianza, Anna, D’Angelo, Alberto, Roviello, Giandomenico, Giudici, Fabiola, Bortul, Marina, Zanconati, Fabrizio, Bottin, Cristina, Generali, Daniele
出版年 Cells (2018)

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

著者: Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
出版年 Int J Mol Sci (2021)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer

著者: Sobhani, Navid, D’Angelo, Alberto, Pittacolo, Matteo, Roviello, Giandomenico, Miccoli, Anna, Corona, Silvia Paola, Bernocchi, Ottavia, Generali, Daniele, Otto, Tobias
出版年 Cells (2019)

Methylene Blue—Current Knowledge, Fluorescent Properties, and Its Future Use

著者: Cwalinski, Tomasz, Polom, Wojciech, Marano, Luigi, Roviello, Giandomenico, D’Angelo, Alberto, Cwalina, Natalia, Matuszewski, Marcin, Roviello, Franco, Jaskiewicz, Janusz, Polom, Karol
出版年 J Clin Med (2020)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

著者: D’Angelo, Alberto, Sobhani, Navid, Chapman, Robert, Bagby, Stefan, Bortoletti, Carlotta, Traversini, Mirko, Ferrari, Katia, Voltolini, Luca, Darlow, Jacob, Roviello, Giandomenico
出版年 Cancers (Basel) (2020)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

著者: D’Angelo, Alberto, Sobhani, Navid, Roviello, Giandomenico, Bagby, Stefan, Bonazza, Deborah, Bottin, Cristina, Giudici, Fabiola, Zanconati, Fabrizio, De Manzini, Nicolo, Guglielmi, Alessandra, Generali, Daniele
出版年 PLoS One (2019)

Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer

著者: Roviello, Giandomenico, Ramello, Monica, Catalano, Martina, D’Angelo, Alberto, Conca, Raffaele, Gasperoni, Silvia, Dreoni, Lorenzo, Petrioli, Roberto, Ianza, Anna, Nobili, Stefania, Aieta, Michele, Mini, Enrico
出版年 Sci Rep (2020)